BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 33649841)

  • 21. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
    Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
    Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.
    Dell'albani P; Rodolico M; Pellitteri R; Tricarichi E; Torrisi SA; D'Antoni S; Zappia M; Albanese V; Caltabiano R; Platania N; Aronica E; Catania MV
    Neuro Oncol; 2014 Jan; 16(2):204-16. PubMed ID: 24305720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation.
    Jia R; Yang L; Yuan X; Kong J; Liu Y; Yin W; Gao S; Zhang Y
    J Oncol; 2019; 2019():1621054. PubMed ID: 31031809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment.
    Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.
    Yao J; Zheng K; Li C; Liu H; Shan X
    Med Oncol; 2015 Jun; 32(6):610. PubMed ID: 25920606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism study of miR-125b in occurrence and progression of multiple myeloma.
    Gao D; Xiao Z; Li HP; Han DH; Zhang YP
    Cancer Med; 2018 Jan; 7(1):134-145. PubMed ID: 29214735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
    Hai L; Zhang C; Li T; Zhou X; Liu B; Li S; Zhu M; Lin Y; Yu S; Zhang K; Ren B; Ming H; Huang Y; Chen L; Zhao P; Zhou H; Jiang T; Yang X
    Cell Death Dis; 2018 Feb; 9(2):158. PubMed ID: 29410396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
    Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
    Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y; Chen H; Zhang J; Chen Y; Wang M; Ma J; Hong L; Liu N; Fan Q; Lu X; Tian Y; Wang A; Dong J; Lan Q; Huang Q
    PLoS One; 2015; 10(11):e0142594. PubMed ID: 26599017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
    Cheng Z; Wang HZ; Li X; Wu Z; Han Y; Li Y; Chen G; Xie X; Huang Y; Du Z; Zhou Y
    J Exp Clin Cancer Res; 2015 Mar; 34(1):27. PubMed ID: 25888093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness.
    Liu L; Tao T; Liu S; Yang X; Chen X; Liang J; Hong R; Wang W; Yang Y; Li X; Zhang Y; Li Q; Liang S; Yu H; Wu Y; Guo X; Lai Y; Ding X; Guan H; Wu J; Zhu X; Yuan J; Li J; Su S; Li M; Cai X; Cai J; Tian H
    Nat Commun; 2021 May; 12(1):2693. PubMed ID: 33976158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
    Zhao ZL; Zhang L; Huang CF; Ma SR; Bu LL; Liu JF; Yu GT; Liu B; Gutkind JS; Kulkarni AB; Zhang WF; Sun ZJ
    Sci Rep; 2016 Apr; 6():24704. PubMed ID: 27108536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.